Crossmark

Sex, Age, and Race Effects on Immunogenicity of MenB-FHbp, A Bivalent Meningococcal B Vaccine: Pooled Evaluation of Clinical Trial Data

Published Online: 2020-07-17

Published Print: 2020-09

Authors

Beeslaar, Johannes

Peyrani, Paula

Absalon, Judith

Maguire, Jason

Eiden, Joseph

Balmer, Paul

Maansson, Roger

Perez, John L.
Funding

Funding for this research was provided by:

Pfizer Inc
License Information

Text and Data Mining valid from 2020-07-17

Version of Record valid from 2020-07-17
More Information

Article History

Received: 8 April 2020

First Online: 17 July 2020

Document is current